ODISEI ONC is a multi-level oncology drug evaluation solution designed to model tumor–immune system interactions. Built on patient-derived organoids (PDOs) that retain the genetic and phenotypic features of original tumors, the platform recreates the tumor microenvironment with increasing immune complexity from ODISEI ONC 1.0 to 4.0.
From basic cancer organoid cultures to advanced co-culture models with immune cells and cytokine signaling, ODISEI ONC enables precise evaluation of tumor–immune interactions, immune evasion, and therapeutic response.
With deep expertise in organoid systems, we support cell-based experiments at every stage — streamlining workflows, reducing operational burden, and ensuring robust, high-quality data generation.
Thank you for applying to VOS Discovery.
We’ve received your application and our team will review your information carefully. If your profile matches the role, we’ll contact you regarding the next steps.
Thank you for sharing your research needs.
VOS Discovery will review your submission and follow up with guidance on the appropriate solution, workflow, or consultation path.
